MIRA INFORM REPORT

 

 

Report Date :

31.10.2013

 

IDENTIFICATION DETAILS

 

Name :

VITAL C HEALTH PRODUCTS  INC.

 

 

Registered Office :

Unit 1902 19th Floor, Centerpoint Bldg., Garnet Road cor. Julia Vargas Ave., Ortigas Center, Pasig City,

 

 

Country :

Philippines

 

 

Financials (as on) :

2012

 

 

Date of Incorporation :

26.02.2007

 

 

Legal Form :

Not Available

 

 

Line of Business :

Distributing, marketing all kinds of goods, products, instruments, commodities, wares & merchandise of every kind and description.

 

 

No. of Employees :

Not Available

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Philippines

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

PHILIPPINES - ECONOMIC OVERVIEW

 

Philippine GDP growth, which cooled from 7.6% in 2010 to 3.9% in 2011, expanded to 6.6% in 2012 - meeting the government's targeted 6%-7% growth range. The 2012 expansion partly reflected a rebound from depressed 2011 export and public sector spending levels. The economy has weathered global economic and financial downturns better than its regional peers due to minimal exposure to troubled international securities, lower dependence on exports, relatively resilient domestic consumption, large remittances from four- to five-million overseas Filipino workers, and a rapidly expanding business process outsourcing industry. The current account balance had recorded consecutive surpluses since 2003; international reserves are at record highs; the banking system is stable; and the stock market was Asia's second best-performer in 2012. Efforts to improve tax administration and expenditure management have helped ease the Philippines' tight fiscal situation and reduce high debt levels. The Philippines received several credit rating upgrades on its sovereign debt in 2012, and has had little difficulty tapping domestic and international markets to finance its deficits. Achieving a higher growth path nevertheless remains a pressing challenge. Economic growth in the Philippines averaged 4.5% during the MACAPAGAL-ARROYO administration but poverty worsened during her term. Growth has accelerated under the AQUINO government, but with limited progress thus far in bringing down unemployment, which hovers around 7%, and improving the quality of jobs. Underemployment is nearly 20% and more than 40% of the employed are estimated to be working in the informal sector. The AQUINO administration has been working to boost the budgets for education, health, cash transfers to the poor, and other social spending programs, and is relying on the private sector to help fund major infrastructure projects under its Public-Private Partnership program. Long term challenges include reforming governance and the judicial system, building infrastructure, improving regulatory predictability, and the ease of doing business, attracting higher levels of local and foreign investments. The Philippine Constitution and the other laws continue to restrict foreign ownership in important activities/sectors (such as land ownership and public utilities)

Source : CIA


 

ANTECEDENT INFORMATION

 

Company:                     VITAL C HEALTH PRODUCTS  INC.

Address:                       Unit 1902 19th Floor, Centerpoint Bldg., Garnet Road cor.

Julia Vargas Ave., Ortigas Center, Pasig City,

Country:                        PHILIPPINES

                 

     

FINDINGS

 

We conducted research and investigation on  VITAL C HEALTH PRODUCTS INC, and showed the following, viz:

 

 

VERIFICATION WITH SECURITIES & EXCHANGE COMMISSION (SEC):  VITAL C HEALTH PRODUCTS

 INC.

 

 

REGISTRATION

 

Certificate No.    :      CS-2007 02971

Date                   :      Feb. 26, 2007

Term                  :      Fifty (50) years

 

Address  :                     Unit 1902 19th Floor, Centerpoint Bldg., F. Ortigas St.  cor. Julia

Vargas Ave., Ortigas Center, Pasig City,

 

                                    Unit 3203 B East Tower, PSE Center, Exchange Road, Ortigas

Center, Pasig City

 

 

CAPITALIZATION    (As of 2013)

 

Authorized Capital Stock                           -      P30,000,000.  – 300,000 Shares 

Amount Subscribed                                   -      P  7,500,000.

Amount Paid Up                                      -      P  7,500,000.                                   

Par value per share                                 -      P            100.   

 

PRIMARY PURPOSE 

 

To engage in, conduct and carry on the business of  distributing, marketing and others, in so far as permitted by law, all kinds of goods, products, instruments, commodities, wares & merchandise of every kind and description.

 

 

ORIGINAL INCORPORATORS – (As of 2007)

 

                Names

Amount Subscribed (Php)

Amount Paid (Php)

   Mario Haw

            562,500

       140.625

   Bernardita Haw

            562,500

       140,625

   Romeo Chua Teco

         1,500,000

       375,000

   Anna Grace D. Chua Teco

         1,500,000

       375,000

   Marciano Bacalla

         3,000,000

       750,000

   Maria Elizabeth Lopez

            375,000

         93,750

             TOTAL

         7,500,000

        vvvvvvvvv

     1,875,000

     vvvvvvvv   

           

 

STOCKHOLDERS (As of 2013)

 

 

      Name / Nationality

 

         Position

Amount Subscribed

     & Paid (Php)

Richard L. King

Chairman & President

      1,623,750

Helen S. Jo

Director

      2,332,500

Wilbert Loa

Treasurer

      1,417,500

Manuel Torrejon, Jr.

Director

      1,134,000

Augusto M. Macam

Corp. Secretary

         283,500

Josephina Torrejon

Director

         708,750

         TOTAL

 

      7,500,000

      vvvvvvvv

 

 

BUSINESS ACTIVITY:  Distributing & Marketing of all kinds of products.                                      

 

Product Lines: 

 

Vital C Sodium Ascorbate                       Vital Clear 90G Soap

Vital P Plus                                            Vital IPOH White Coffee

Vital Life                                              Hand Sanitizers

Bio Skin 90G Soap

 

     

BUSINESS ADDRESS:   Unit 1902 19th Floor, Centerpoint Bldg., F. Ortigas St.  cor. Julia Vargas Ave.

                                        Ortigas Center, Pasig City. Telephone No. (632) 631-1899. Website: www.vitalc.com 

 

              Ortigas Depot  :  Units G4,5 & 6 Grd. Flr., BSA  Twin Tower Bank Drive, Ortigas Center, Mandaluyong.

                                       Tel. Nos. (632) 654- 4890 / 96.

 

              Cebu Depot    :   Units G11-13, Grd. Flr., Tower Mall, Fuente Tower 3, Osmeña Blvd., Cebu City.

                                        Tel. Nos. (63 32) 418-2927    /    418-7777.

 

              Davao Depot  :    Sobrecary St., Bo. Obrero, Davao City. Tel. Nos. (63 82) 227-3069 / 227-8482.

 

 

FINANCIAL CONDITION

 

(Audited Financial Statement for years 2012, 2011, & 2010, as compiled)

 

 

Balance Sheet 

 

 

    2012 (Php)

  2011 (Php)

 2010 (Php)

                             Assets

 

 

 

Current Assets

 

 

 

     Cash & Cash equivalents

    9,672,152

     8,129,997

     8,401,102

     Trade & Other Receivables

       745,545

        656,244

        220,360

     Inventory

   27,478,599   

   32,908,347

   31,407,622

     Other Receivables

    3,387,575

     3,387,575

     3,387,575

     Other Current Assets

    4,206,362

     4,659,328

     2,341,215

       Total Current Assets

  45,490,233

   49,741,490

   45,757,874

Non-Current Assets

 

 

 

      Advances & Deposits

       119,880

        119,880

        119,880

     Property & Equipment, net

  72,183,138

   44,040,133

   22,499,048

Total Non-Current Assets

  72,303,018

   44,160,013

   22,619,828

TOTAL ASSETS

117,793,251

vvvvvvvvvvv

   93,901,503

vvvvvvvvvvvv

   68,377,702

vvvvvvvvvvvv

 

 

 

 

Liabilities & Stockholder’s Equity

 

 

 

Current Liabilities

 

 

 

Trade & other Payables

49,344,335

62,535,125

45,693,650

Notes Payable

4,481,992

476,490

806,351

Loan Payable

41,485,714

9,100,000

11,040,155

Income Tax Payable

158,085

151,026

92,507

Other  Current Liabilities

308,997

351,686

191,844

Total Current Liabilities

95,779,122

72,614,327

57,824,546

 

 

 

 

Non Current Liabilities

 

 

 

Advances from Stockholders

17,061,690

17,061,690

7,061,690

Total Non Current Liabilities

17,061,690

17,061,690

7,061,690

TOTAL LIABILITIES

112,840,812

89,676.017

64,886,236

 

 

 

 

Stockholder’s Equity

 

 

 

Authorized Capial Stock – P30,000,000

 

 

 

Paid Up Capital

7,500,000

7,500,000

7,500,000

Retained Earnings

(2,547,561)

(3,274,514)

(4,008,534)

TOTAL STOCKHOLDER’S EQUITY

4,952,439

4,225,486

3.401,466

TOTAL LIABILITIES &

STOCKHOLDERS EQUITY

 

117,793,251

vvvvvvvvvvv

 

93,901,503

vvvvvvvvvvv

 

68,377,702

vvvvvvvvvvvv

 

 

 

 

 

Income Statement

 

 

 

Revenues

74,419,007

70,901,143

65,747,567

Gross Profit

31,876,828

30,913,467

28,147,588

General  & Admin.  Expenses

30,222,690

29,965,741

26,888,516

Income from operation

1,654,138

947,726

1,259,070

Other Income/(Charges)

 

 

 

Gain from Sale of Vehicle

42,227

NIL

NIL

Interest Income

24,158

70,612

19,848

Net Income before Tax

1,720,524

1,018,338

1,278,918

Net Profit

1,077,790

vvvvvvvvvvvvv

734,020

vvvvvvvvvvvv

901,197

vvvvvvvvvvvv

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

“Manuel A. Torrejon, Jr., about 65 years old, Chief Operating Officer of Vital C Health Product,

Inc.”

 

“Vital C welcomes Dr. Jose M. Oclarit, a PHD in Applied BioChemistry & Bio Molecular Biology;

one of the Outstanding Young Scientist of the Phils., as AVP for Research and Product

Development.”


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.49

UK Pound

1

Rs.98.71

Euro

1

Rs.84.49

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIS

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.